TMT (technology, media and telecoms)
Renowned for its proficiency in high-profile patent litigation and big-ticket transactions – including M&A, licensing and collaborations – A&O Shearman advises across the full spectrum of life sciences, supporting global pharmaceutical, growth-stage and consumer healthcare companies. The ‘professional, efficient and effective’ team also handles regulatory, antitrust, employment, and investigations matters. The practice is jointly led by Matthew Appleton, noted for his ’innovative’ transaction structuring; Jim Ford, IP and commercial specialist at the forefront of AI and machine learning in drug development; and Marjan Noor, an expert in life sciences patents and regulatory law. Rafi Allos focuses on contentious patent matters and regulatory advice, while Megan McMellon combines expertise in cross-border IP transactions and commercial agreements. The team’s IP capabilities were strengthened by the arrival of Gemma Barrett from Bristows LLP in February 2024.
Legal 500 Editorial commentary
- Profile
Mentions
Testimonials
Collated independently by Legal 500 research team.
‘The team provides seamless services across a wide range of work streams that cut across multiple complex fields of law in a professional, efficient, and effective manner - and in the process delivers an end product that is best of breed.’
‘They provide comprehensive support, involving European and American team members as necessary, for a wide range of matters, including licensing agreements for life science technologies, small and large cross-border M&A deals, investments in venture companies, and the establishment of joint ventures.’ ‘Deep knowledge of the important aspects around the complicated interface between law, deal-making and biotech.’ ‘In and amongst a world-class Health Sciences M&A team, Matthew Appleton and Gareth Irving bear mentioning as stand-out lawyers. These individuals operate together as an incredibly well-oiled machine, producing top-quality solutions to complex legal problems. Matthew's approach to transaction structuring is visionary, as he creates innovative solutions for key issues that could otherwise become deal breakers. Gareth is a leading strategic legal mind with an outstanding ability to craft top-drawer agreements that are incredibly well considered and designed to offer solid protection in the face of potential dispute.’‘Megan McMellon and Jim Ford, in particular, are very collaborative and easy to work with, as well as hard-working and smart.’
‘Marjan Noor and Tom Edwards are excellent.’
‘Jim Ford and Megan McMellon and their team persistently carry out risk assessments and propose the optimal structure even when we propose a highly complex transaction structure. They are persistent in dealing with projects that seem very difficult to carry out. They are always there for the clients. ’
Key clients
- Bayer Exscientia BioNtech Haleon Life Healthcare Mallinckrodt Shionogi GSK Optima Health Goldman Sachs